Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma

BMC Cancer. 2022 Jun 16;22(1):661. doi: 10.1186/s12885-022-09765-0.

Abstract

Background: Intratumoral fibrosis was positively correlated with histological grade of renal clear cell carcinoma (ccRCC) and intratumoral inflammation. However, the association of intratumoral fibrosis with the immune infiltration of ccRCC was few evaluated.

Methods: We used the second harmonic generation (SHG)-based imaging technology and evaluated the intratumoral fibrosis in ccRCC, and then divided the patients into the high fibrosis group (HF) and the low fibrosis group (LF). Meanwhile, the Kaplan-Meier survival curve analysis was performed to analyze the relationship between intratumoral fibrosis and the disease-free survival rate. Antibody arrays were used for seeking difference in cytokines and immune infiltration between the HF group (N = 11) and LF group (N = 11). The selected immune infiltration marker was then verified by immunohistochemistry (IHC) staining in 45 ccRCC samples.

Results: Out of 640 cytokines and immune infiltration markers, we identified 115 proteins that were significantly different in quantity between ccRCC and adjacent normal tissues. In addition, the Venn diagram indicated that six proteins, including Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA4), were significantly associated with intratumoral fibrosis (p < 0.05). The GO/KEGG enrichment analysis indicated that the proteins associated with intratumoral fibrosis were involved in the immunity and tumor-infiltrating lymphocytes. The expression of the CTLA4 was negatively correlated with collagen level, confirmed by IHC staining of CTLA4 (p < 0.05).

Conclusions: The study indicated that the intratumoral fibrosis level was negatively correlated with the expression of CTLA4 in the tumor immune microenvironment of the ccRCC, which posed the potential value of targeting the stroma of the tumor, a supplement to immunotherapy. However, the specific mechanism of this association is still unclear and needs further investigation.

Keywords: CTLA4; Immunotherapy; Tumor microenvironment; ccRCC.

MeSH terms

  • Biomarkers, Tumor / metabolism
  • CTLA-4 Antigen
  • Carcinoma, Renal Cell* / pathology
  • Cytokines
  • Fibrosis
  • Humans
  • Kidney Neoplasms* / pathology
  • Prognosis
  • Tumor Microenvironment

Substances

  • Biomarkers, Tumor
  • CTLA-4 Antigen
  • Cytokines